Delirium drug may not benefit critically ill patients, study finds

08/20/2013 | HealthDay News

The antipsychotic drug haloperidol was no more effective than placebo in treating delirium in critically ill patients, according to a study in The Lancet Respiratory Medicine. Researchers tracked 141 seriously ill patients and found that the drug had no effect on length of delirium. Haloperidol also failed to cut death rates, time on ventilators or duration of hospitalization.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC